Cellectis bioresearch, a specialist in genome customization and subsidiary of Cellectis (Alternext: ALCLS), has today launched TALEN Access™, the first fee-for-service custom TALEN.
Recognized as a pioneer in the development of innovative research products for genome customization, Cellectis bioresearch brings today the life sciences community a new tool for specifically modifying genes in any type of cell.
The service will start with the TALEN Access™ offer, which provides a pair of TALENs for 5,000 euro/US$, delivered in less than 3 weeks.
"What we are offering here is a true commercial revolution," said Luc Selig, VP Sales and Marketing at Cellectis bioresearch. "We are keeping our promise to make genome customization affordable for the hundred of thousands academic research labs."
Does IBD affect cancer risk?